FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ferdinando NMN Dianzani

Research Profile

Living Beings

HIV-1
HIV

Chemicals & Drugs

Anatomy

Physiology

Disorders

Procedures

Neutralization Tests

Co-author Network

Publications

TOP 3
Gianpiero D'Offizi; Federico Martini; Gabriella Rozera; Isabella Abbate; Maria Rosaria Capobianchi; Pasquale Narciso; Ferdinando NMN Dianzani
Comment on Neumann et al. 'Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients'.
Ferdinando NMN Dianzani; Gabriella Rozera; Isabella Abbate; Gianpiero D'Offizi; Amina Abdeddaim; Chrysoula Vlassi; Giorgio Antonucci; Pasquale Narciso; Federico Martini; Maria R Capobianchi
Interferon may prevent HIV viral rebound after HAART interruption in HIV patients.
Elisabetta Riva; Diego Serraino; Alessandra Pierangeli; Federica Bambacioni; Stefania Zaniratti; Claudia Minosse; Marina Selleri; Mauro Bucci; Carolina Scagnolari; Anna Marta Degener; Maria Rosaria Capobianchi; Guido Antonelli; Ferdinando NMN Dianzani
Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ferdinando NMN Dianzani (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Gianpiero D'Offizi; Federico Martini; Gabriella Rozera; Isabella Abbate; Maria Rosaria Capobianchi; Pasquale Narciso; Ferdinando NMN Dianzani
Comment on Neumann et al. 'Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients'.
AIDS (London, England) 2008;22(2):321.
2008: Ferdinando NMN Dianzani; Gabriella Rozera; Isabella Abbate; Gianpiero D'Offizi; Amina Abdeddaim; Chrysoula Vlassi; Giorgio Antonucci; Pasquale Narciso; Federico Martini; Maria R Capobianchi
Interferon may prevent HIV viral rebound after HAART interruption in HIV patients.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2008;28(1):1-3.
2007: Elisabetta Riva; Diego Serraino; Alessandra Pierangeli; Federica Bambacioni; Stefania Zaniratti; Claudia Minosse; Marina Selleri; Mauro Bucci; Carolina Scagnolari; Anna Marta Degener; Maria Rosaria Capobianchi; Guido Antonelli; Ferdinando NMN Dianzani
Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2007;13(1):94-7.
2006: Maria Rosaria Capobianchi; Eleonora Lalle; F Martini; Fabrizio Poccia; Gianpiero D'Offizi; Giorgio Antonucci; Isabella Abbate; Ferdinando NMN Dianzani
Influence of GBV-C infection on the endogenous activation of the IFN system in HIV-1 co-infected patients.
Cellular and molecular biology (Noisy-le-Grand, France) 2006;52(1):3-8.
2005: Guido Antonelli; Francesca Bagnato; Ferdinando NMN Dianzani
Considerations on the development of serum antibodies to interferon-beta.
The new microbiologica 2005;28(3):183-92.
2005: Isabella Abbate; Giuseppina Cappiello; Roberta Longo; Antonella Ursitti; Alberto Spanò; Silvia Calcaterra; Ferdinando NMN Dianzani; Andrea Antinori; Maria Rosaria Capobianchi
Cell membrane proteins and quasispecies compartmentalization of CSF and plasma HIV-1 from aids patients with neurological disorders.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2005;5(3):247-53.
2004: Carolina Scagnolari; Elisa Vicenzi; Francesca Bellomi; Maria Giuseppina Stillitano; Debora Pinna; Guido Poli; Massimo Clementi; Ferdinando NMN Dianzani; Guido Antonelli
Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons.
Antiviral therapy 2004;9(6):1003-11.
2003: Elisabetta Riva; Guido Antonelli; Carolina Scagnolari; Mauro Pistello; Maria Rosaria Capobianchi; Antonella d'Arminio Monforte; Patrizio Pezzotti; Ferdinando NMN Dianzani
Human immunodeficiency virus (HIV) DNA load and level of immunosuppression in treatment-naive HIV-1-infected patients.
The Journal of infectious diseases 2003;187(11):1826-8.
2003: Carolina Scagnolari; Milvia Casato; Francesca Bellomi; Francesca De Pisa; Ombretta Turriziani; Rossella Coviello; Maria Rosaria Pirro; Ferdinando NMN Dianzani; Guido Antonelli
Serum interferon (IFN)-neutralizing antibodies and bioactivities of IFNs in patients with severe type II essential mixed cryoglobulinemia.
Clinical and diagnostic laboratory immunology 2003;10(1):70-7.
2002: Ferdinando NMN Dianzani; Guido Antonelli; Elisabetta Riva; Ombretta Turriziani; Laura Antonelli; Stephen Tyring; Daniel A Carrasco; Hung Lee; Derrick Nguyen; Jingzhi Pan; Joyce Poast; Miles W Cloyd; Samuel Baron
Is human immunodeficiency virus RNA load composed of neutralized immune complexes?
The Journal of infectious diseases 2002;185(8):1051-4.
2001: E Riva; Mauro Pistello; Pasquale Narciso; Gianpiero D'Offizi; Patrizia Isola; Vincenzo Galati; Ombretta Turriziani; Valerio Tozzi; L Vincenzi; Ferdinando NMN Dianzani; Guido Antonelli
Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy.
AIDS research and human retroviruses 2001;17(17):1599-604.
2001: Isabella Abbate; Ferdinando NMN Dianzani; Ombretta Turriziani; Guido Antonelli; Gianpiero D'Offizi; Vincenzo Galati; Marina Pierdominici; Franco Pandolfi; Maria Rosaria Capobianchi
Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2.
AIDS (London, England) 2001;15(1):11-6.
2000: Isabella Abbate; Ferdinando NMN Dianzani; Maria Rosaria Capobianchi
Activation of signal transduction and apoptosis in healthy lymphomonocytes exposed to bystander HIV-1-infected cells.
Clinical and experimental immunology 2000;122(3):374-80.
2000: Ombretta Turriziani; Guido Antonelli; Ferdinando NMN Dianzani
Cellular factors involved in the induction of resistance of HIV to antiretroviral agents.
International journal of antimicrobial agents 2000;16(3):353-6.
2000: Ferdinando NMN Dianzani; Guido Antonelli; Fernando Aiuti; Ombretta Turriziani; Elisabetta Riva; Maria Rosaria Capobianchi; Franco Pandolfi; Gianpiero D'Offizi
The number of HIV DNA-infected mononuclear cells is reduced under HAART plus recombinant IL-2. IRHAN Study Group.
Antiviral research 2000;45(2):95-9.
2000: Ombretta Turriziani; Pierangelo Di Marco; G Antonelli; Ferdinando NMN Dianzani
May the drug transporter P glycoprotein affect the antiviral activity of human immunodeficiency virus type 1 proteinase inhibitors?
Antimicrobial agents and chemotherapy 2000;44(2):473-4.
2000: Elisabetta Riva; Guido Antonelli; Mariacarmela Solmone; Ombretta Turriziani; Pasquale Narciso; Valerio Tozzi; Ferdinando NMN Dianzani
Significant reduction in HIV-1 plasma viral load but not in proviral infected cells during sub-optimal antiretroviral therapy.
Journal of biological regulators and homeostatic agents 2000;14(1):1-3.
1999: Andrea Savarino; Flavia Bottarel; Liliana Calosso; Maria Jose Feito; Thea Bensi; M Bragardo; J M Rojo; Agostino Pugliese; Isabella Abbate; M R Capobianchi; Ferdinando NMN Dianzani; Fabio Malavasi; Umberto Dianzani
Effects of the human CD38 glycoprotein on the early stages of the HIV-1 replication cycle.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1999;13(15):2265-76.
1999: Guido Antonelli; E Simeoni; Francesca Bagnato; C Pozzilli; Ombretta Turriziani; R Tesoro; Pierangelo Di Marco; Claudio Gasperini; Cesare Fieschi; Ferdinando NMN Dianzani
Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b.
Journal of the neurological sciences 1999;168(2):131-6.
1999: Ferdinando NMN Dianzani
Chronic hepatitis B, biological basis for new therapeutic strategies.
Journal of biological regulators and homeostatic agents 1999;13(2):71-9.
1999: Isabella Abbate; Ferdinando NMN Dianzani; F Bianchi; Giovanni Mosiello; Fabrizio Carletti; D Fiumara; Maria Rosaria Capobianchi
RANTES stimulates cell-mediated transmission of HIV-1 infection.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1999;19(4):345-50.
1999: GC Viscomi; Guido Antonelli; C Bruno; L Scapol; F Malavasi; A Funaro; E Simeoni; S Pestka; Francesca De Pisa; Ferdinando NMN Dianzani
Antigenic characterization of recombinant, lymphoblastoid, and leukocyte IFN-alpha by monoclonal antibodies.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1999;19(4):319-26.
1999: Guido Antonelli; E Simeoni; Ombretta Turriziani; R Tesoro; A Redaelli; Luigi Roffi; Laura Antonelli; Mauro Pistello; Ferdinando NMN Dianzani
Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1999;19(3):243-51.
1999: Isabella Abbate; Fabrizio Carletti; Ferdinando NMN Dianzani; Maria Rosaria Capobianchi
RANTES upregulation by HIV-1-infected cells: lack of correlation with viral replication and induction of interferon.
AIDS (London, England) 1999;13(2):288-90.
1998: Ferdinando NMN Dianzani; Concetta Castilletti; M Gentile; H R Gelderblom; F Frezza; Maria Rosaria Capobianchi
Effects of IFN alpha on late stages of HIV-1 replication cycle.
Biochimie 1998;80(8-9):745-54.
1998: Guido Antonelli; Francesca Bagnato; C Pozzilli; E Simeoni; S Bastianelli; M Currenti; Francesca De Pisa; Cesare Fieschi; Claudio Gasperini; M Salvetti; Ferdinando NMN Dianzani
Development of neutralizing antibodies in patients with relapsing-remitting multiple sclerosis treated with IFN-beta1a.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1998;18(5):345-50.
1998: Ferdinando NMN Dianzani; Guido Antonelli
What is the practical significance of antibodies to interferons?
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 1998;9(3):187-95.
1998: Maria Rosaria Capobianchi; Isabella Abbate; Guido Antonelli; Ombretta Turriziani; Antonina Dolei; Ferdinando NMN Dianzani
Inhibition of HIV type 1 BaL replication by MIP-1alpha, MIP-1beta, and RANTES in macrophages.
AIDS research and human retroviruses 1998;14(3):233-40.
1998: Antonina Dolei; Adriana Biolchini; Caterina Serra; Sabrina Curreli; E Gomes; Ferdinando NMN Dianzani
Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines.
AIDS (London, England) 1998;12(2):183-90.
1998: Ombretta Turriziani; E Simeoni; Ferdinando NMN Dianzani; Guido Antonelli
Anti-HIV antiviral activity of stavudine in a thymidine kinase-deficient cellular line.
Antiviral therapy 1998;3(3):191-4.
1998: Ferdinando NMN Dianzani; Guido Antonelli; Ombretta Turriziani
Resistance of HIV to antiretroviral agents. Basic concepts.
Journal of biological regulators and homeostatic agents 1998;12(1-2 Suppl):19-22.
1997: C Signoretti; Giulia Romagnoli; Ombretta Turriziani; G Antonelli; Ferdinando NMN Dianzani; Maurizio Cianfriglia
Induction of the multidrug-transporter P-glycoprotein by 3'-azido-3'-deoxythymidine (AZT) treatment in tumor cell lines.
Journal of experimental & clinical cancer research : CR 1997;16(1):29-32.
1997: Maria Rosaria Capobianchi; C Barresi; Paola Borghi; Sandra Gessani; Laura Fantuzzi; F Ameglio; Filippo Belardelli; S Papadia; Ferdinando NMN Dianzani
Human immunodeficiency virus type 1 gp120 stimulates cytomegalovirus replication in monocytes: possible role of endogenous interleukin-8.
Journal of virology 1997;71(2):1591-7.
1997: Guido Antonelli; E Simeoni; M Currenti; Francesca De Pisa; V Colizzi; Mauro Pistello; Ferdinando NMN Dianzani
Interferon antibodies in patients with infectious diseases. Anti-interferon antibodies.
Biotherapy (Dordrecht, Netherlands) 1997;10(1):7-14.
1996: Ombretta Turriziani; Guido Antonelli; F Focher; F Bambacioni; Ferdinando NMN Dianzani
Further study of the mechanism underlying the cellular resistance to AZT.
Biochemical and biophysical research communications 1996;228(3):797-801.
1996: H Ankel; Maria Rosaria Capobianchi; F Frezza; C Castilletti; Ferdinando NMN Dianzani
Interferon induction by HIV-1-infected cells: a possible role of sulfatides or related glycolipids.
Virology 1996;221(1):113-9.
1996: Guido Antonelli; Gianluigi Giannelli; M Currenti; E Simeoni; S Del Vecchio; Fabrizio Maggi; Mauro Pistello; L Roffi; Giuseppe Pastore; L Chemello; Ferdinando NMN Dianzani
Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-alpha2 therapy.
Clinical and experimental immunology 1996;104(3):384-7.
1996: daniela bellarosa; Guido Antonelli; F Bambacioni; D Giannotti; G Viti; R Nannicini; A Giachetti; Ferdinando NMN Dianzani; M Witvrouw; R Pauwels; J Desmyter; E De Clercq
New arylpyrido-diazepine and -thiodiazepine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase.
Antiviral research 1996;30(2-3):109-24.
1996: Ferdinando NMN Dianzani; O Scheglovitova; M Gentile; V Scanio; C Barresi; B Ficociello; F Bianchi; D Fiumara; Maria Rosaria Capobianchi
Interferon gamma stimulates cell-mediated transmission of HIV type 1 from abortively infected endothelial cells.
AIDS research and human retroviruses 1996;12(7):621-7.
1996: Guido Antonelli; Ombretta Turriziani; A Verri; Pasquale Narciso; Fabio Massimo Ferri; Gianpiero D'Offizi; Ferdinando NMN Dianzani
Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase.
AIDS research and human retroviruses 1996;12(3):223-8.
1995: M Milella; Guido Antonelli; Teresa Santantonio; Gianluigi Giannelli; M Currenti; Laura Monno; Ombretta Turriziani; Giuseppe Pastore; Ferdinando NMN Dianzani
Treatment with natural IFN of hepatitis C patients with or without antibodies to recombinant IFN.
Hepato-gastroenterology 1995;42(3):201-4.
1995: C Castilletti; Maria Rosaria Capobianchi; Stefano Fais; Isabella Abbate; B Ficociello; Franco Ameglio; Paola Cordiali Fei; Stefano M Santini; Ferdinando NMN Dianzani
HIV type 1 grown on interferon gamma-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells.
AIDS research and human retroviruses 1995;11(5):547-53.
1995: Ombretta Turriziani; Guido Antonelli; A Verri; Valerio Tozzi; Fabio Massimo Ferri; E Riva; F Bambacioni; Ferdinando NMN Dianzani
Alteration of thymidine kinase activity in cells treated with an antiviral agent.
Journal of biological regulators and homeostatic agents 1995;9(2):47-51.
1995: Stefano Fais; Maria Rosaria Capobianchi; Isabella Abbate; C Castilletti; M Gentile; Paola Cordiali Fei; Franco Ameglio; Ferdinando NMN Dianzani
Unidirectional budding of HIV-1 at the site of cell-to-cell contact is associated with co-polarization of intercellular adhesion molecules and HIV-1 viral matrix protein.
AIDS (London, England) 1995;9(4):329-35.
1995: Antonello Giovannetti; Alessandro Aiuti; P M Pizzoli; Marina Pierdominici; E Agostini; A Oliva; Ferdinando NMN Dianzani; Fernando Aiuti; Franco Pandolfi
Tyrosine phosphorylation pathway is involved in interferon-gamma (IFN-gamma) production; effect of sodium ortho vanadate.
Clinical and experimental immunology 1995;100(1):157-63.
1995: O Scheglovitova; V Scanio; Stefano Fais; S Papadia; Isabella Abbate; C Castilletti; Ferdinando NMN Dianzani; Maria Rosaria Capobianchi
Antibody to ICAM-1 mediates enhancement of HIV-1 infection of human endothelial cells.
Archives of virology 1995;140(5):951-8.
1995: Isabella Abbate; Maria Rosaria Capobianchi; Stefano Fais; C Castilletti; F Mercuri; Paola Cordiali Fei; Franco Ameglio; Ferdinando NMN Dianzani
Host cell antigenic profile acquired by HIV-1 is a marker of its cellular origin.
Archives of virology 1995;140(10):1849-54.
1994: Maria Rosaria Capobianchi; Caterina Serra; Isabella Abbate; P Marongiu; C Castilletti; F Tilocca; Ferdinando NMN Dianzani; Antonina Dolei
Treatment of HIV-infected fibroblasts with human leukocyte antigen (HLA)-DR-inductive cytokines leads to infectious virions with newly acquired HLA-DR.
AIDS (London, England) 1994;8(12):1731-3.
1994: H Ankel; Maria Rosaria Capobianchi; C Castilletti; Ferdinando NMN Dianzani
Interferon induction by HIV glycoprotein 120: role of the V3 loop.
Virology 1994;205(1):34-43.
1994: Ferdinando NMN Dianzani; Guido Antonelli; Ombretta Turriziani; E Riva; E Simeoni; C Signoretti; S Strosselli; Maurizio Cianfriglia
Zidovudine induces the expression of cellular resistance affecting its antiviral activity.
AIDS research and human retroviruses 1994;10(11):1471-8.
1994: Stefano Fais; Maria Rosaria Capobianchi; M Silvestri; F Mercuri; Francesco Pallone; Ferdinando NMN Dianzani
Interferon expression in Crohn's disease patients: increased interferon-gamma and -alpha mRNA in the intestinal lamina propria mononuclear cells.
Journal of interferon research 1994;14(5):235-8.
1994: Ombretta Turriziani; Guido Antonelli; Helmut Jacobsen; J Mous; E Riva; M Pistello; Ferdinando NMN Dianzani
Identification of an amino acid substitution involved in the reduction of sensitivity of HIV-1 to an inhibitor of viral proteinase.
Acta virologica 1994;38(5):297-8.
1994: Antonina Dolei; Caterina Serra; M V Arca; F Tilocca; E Riva; G Antonelli; Ferdinando NMN Dianzani; Antonio Toniolo
Infectious virus with reduced cytopathogenicity resulting from persistent infection of normal lung fibroblasts by HIV type 1 strains.
AIDS research and human retroviruses 1994;10(9):1089-95.
1994: Guido Antonelli; Gianluigi Giannelli; Mauro Pistello; Fabrizio Maggi; L Vatteroni; M Currenti; S Del Vecchio; L Roffi; Giuseppe Pastore; Ferdinando NMN Dianzani
Clinical significance of recombinant interferon-alpha 2 neutralizing antibodies in hepatitis patients.
Journal of interferon research 1994;14(4):211-3.
1994: Gianluigi Giannelli; Guido Antonelli; G Fera; S Del Vecchio; E Riva; C Broccia; Oronzo Schiraldi; Ferdinando NMN Dianzani
Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN-alpha) during therapy for chronic hepatitis C.
Clinical and experimental immunology 1994;97(1):4-9.
1994: Maria Rosaria Capobianchi; Stefano Fais; C Castilletti; M Gentile; Franco Ameglio; Ferdinando NMN Dianzani
A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles.
The Journal of infectious diseases 1994;169(4):886-9.
1994: Milvia Casato; Guido Antonelli; Fabrizio Maggi; Leopoldo Paolo Pucillo; L Di Lullo; M Leoni; M Currenti; Ferdinando NMN Dianzani; Lorenzo Bonomo
Resistance to recombinant alpha interferon therapy in idiopathic mixed cryoglobulinemia: reinduction of remission by natural alpha interferon both in antibody-positive and -negative patients.
Journal of biological regulators and homeostatic agents 1994;8(2):56-9.
1994: Franco Ameglio; Maria Rosaria Capobianchi; C Castilletti; Paola Cordiali Fei; Stefano Fais; Elisabetta Trento; Ferdinando NMN Dianzani
Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells; correlation with the induction of other cytokines.
Clinical and experimental immunology 1994;95(3):455-8.
1993: Maria Rosaria Capobianchi; Franco Ameglio; Paola Cordiali Fei; C Castilletti; F Mercuri; Stefano Fais; Ferdinando NMN Dianzani
Coordinate induction of interferon alpha and gamma by recombinant HIV-1 glycoprotein 120.
AIDS research and human retroviruses 1993;9(10):957-62.
1993: M Milella; Guido Antonelli; Teresa Santantonio; M Currenti; Laura Monno; N Mariano; Gioacchino Angarano; Ferdinando NMN Dianzani; Giuseppe Pastore
Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection.
Liver 1993;13(3):146-50.
1993: Gianluigi Giannelli; Guido Antonelli; G Fera; Ferdinando NMN Dianzani; Oronzo Schiraldi
2',5'-Oligoadenylate synthetase activity as a responsive marker during interferon therapy for chronic hepatitis C.
Journal of interferon research 1993;13(1):57-60.
1993: Maria Rosaria Capobianchi; P Mattana; Ferdinando NMN Dianzani
Potentiation of interferon-alpha in vitro antiviral activity by interferon-gamma is not abrogated by antibody to interferon-gamma.
Journal of interferon research 1993;13(1):53-5.
1993: O Scheglovitova; Maria Rosaria Capobianchi; G Antonelli; D Guanmu; Ferdinando NMN Dianzani
CD4-positive lymphoid cells rescue HIV-1 replication from abortively infected human primary endothelial cells.
Archives of virology 1993;132(3-4):267-80.
1993: Ferdinando NMN Dianzani
Biological basis for the clinical use of interferon.
Gut 1993;34(2 Suppl):S74-6.
1992: Maria Rosaria Capobianchi; P Mattana; F Mercuri; G Conciatori; Franco Ameglio; H Ankel; Ferdinando NMN Dianzani
Acid lability is not an intrinsic property of interferon-alpha induced by HIV-infected cells.
Journal of interferon research 1992;12(6):431-8.
1992: Maria Rosaria Capobianchi; Stefano Fais; M C Di Paolo; D Agostini; P Paoluzi; Francesco Pallone; Ferdinando NMN Dianzani
Absence of circulating interferon in patients with inflammatory bowel disease. Suggestion against an autoimmune etiology.
Clinical and experimental immunology 1992;90(1):85-7.
1992: Guido Antonelli; Ombretta Turriziani; Maurizio Cianfriglia; E Riva; G Dong; A Fattorossi; Ferdinando NMN Dianzani
Resistance of HIV-1 to AZT might also involve the cellular expression of multidrug resistance P-glycoprotein.
AIDS research and human retroviruses 1992;8(10):1839-44.
1992: Maria Rosaria Capobianchi; Stefano Fais; F Mercuri; Monica Boirivant; Ferdinando NMN Dianzani; Francesco Pallone
Interferon-alpha (IFN-alpha) production by human intestinal mononuclear cells. Response to virus in control subjects and in Crohn's disease.
Gut 1992;33(7):897-901.
1992: Ferdinando NMN Dianzani; Guido Antonelli; Ombretta Turriziani; G Dong; Maria Rosaria Capobianchi; E Riva
In vitro selection of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine.
Antiviral research 1992;18(1):39-52.
1992: Maria Rosaria Capobianchi; H Ankel; Franco Ameglio; Roberto Paganelli; P M Pizzoli; Ferdinando NMN Dianzani
Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer.
AIDS research and human retroviruses 1992;8(5):575-9.
1992: P Tolentino; Ferdinando NMN Dianzani; M Zucca; R Giacchino
Decreased interferon response by lymphocytes from children with chronic hepatitis.
Journal of interferon research 1992;Spec No():3-6.
1992: Ferdinando NMN Dianzani
Interferon treatments: how to use an endogenous system as a therapeutic agent.
Journal of interferon research 1992;Spec No():109-18.
1992: Guido Antonelli; M Currenti; Ombretta Turriziani; E Riva; Ferdinando NMN Dianzani
Relative frequency of nonneutralizing antibodies to interferon (IFN) in hepatitis patients treated with different IFN-alpha preparations.
The Journal of infectious diseases 1992;165(3):593-4.
1992: Ferdinando NMN Dianzani; Guido Antonelli; Ombretta Turriziani; E Riva
[Acquired immunodeficiency virus (HIV-1). Biological aspects and virological diagnosis].
La Clinica terapeutica 1992;140(2):179-86.
1991: Milvia Casato; Bruno Laganà; Guido Antonelli; Ferdinando NMN Dianzani; Lorenzo Bonomo
Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia.
Blood 1991;78(12):3142-7.
1991: Maria Rosaria Capobianchi; P Mattana; M Gentile; G C Conciatori; H Ankel; Ferdinando NMN Dianzani
Role of glycosilation in the susceptibility of "acid labile" interferon alpha to acid treatment.
Journal of biological regulators and homeostatic agents 1991;5(4):147-53.
1991: Stefano Fais; Maria Rosaria Capobianchi; Francesco Pallone; Pierangelo Di Marco; Monica Boirivant; Ferdinando NMN Dianzani; A Torsoli
Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers.
Gut 1991;32(4):403-7.
1991: Guido Antonelli; M Currenti; Ombretta Turriziani; Ferdinando NMN Dianzani
Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations.
The Journal of infectious diseases 1991;163(4):882-5.
1991: E Soldaini; Donatella Matteucci; Maria Rosaria Capobianchi; F Baldinotti; Antonello Giovannetti; Ferdinando NMN Dianzani; Mauro Bendinelli
Alterations of T-cell functions during Friend leukemia complex infection: defective signal transduction?
Viral immunology 1991;4(3):139-49.
1991: Maria Rosaria Capobianchi; Donatella Matteucci; Antonello Giovannetti; E Soldaini; Mauro Bendinelli; J G Stanton; Ferdinando NMN Dianzani
Role of interferon in lethality and lymphoid atrophy induced by Coxsackievirus B3 infection in mice.
Viral immunology 1991;4(2):103-10.
1990: Maria Rosaria Capobianchi; F Malavasi; P Mattana; F Mercuri; Ferdinando NMN Dianzani
Membrane interactions involved in the induction of acid labile interferon alpha.
Journal of biological regulators and homeostatic agents 1990;4(1):19-24.
1990: Milvia Casato; Bruno Laganà; Alessandra Giorgi; Guido Antonelli; Ferdinando NMN Dianzani
Clinical effects of interferon in patients with idiopathic mixed cryoglobulinemia.
European journal of haematology. Supplementum 1990;52():7-8.
1990: Ferdinando NMN Dianzani; Guido Antonelli; M R Capobianchi
The biological basis for clinical use of interferon.
Journal of hepatology 1990;11 Suppl 1():S5-10.
1989: Ferdinando NMN Dianzani; Guido Antonelli; P Amicucci; A Cefaro; C Pintus
Low incidence of neutralizing antibody formation to interferon-alpha 2b in human recipients.
Journal of interferon research 1989;9 Suppl 1():S33-6.
1989: Ferdinando NMN Dianzani; Maria Rosaria Capobianchi; Guido Antonelli; P Amicucci; F De Marco
Susceptibility of human immunodeficiency virus to antiviral agents measured by infectious virus yield reduction.
Antiviral research 1989;11(5-6):299-305.
1989: V Ruggiero; Guido Antonelli; M Gentile; G Conciatori; Ferdinando NMN Dianzani
Comparative study on the antiviral activity of tumor necrosis factor (TNF)-alpha, lymphotoxin/TNF-beta, and IL-1 in WISH cells.
Immunology letters 1989;21(2):165-9.
1989: Ferdinando NMN Dianzani; Maria Rosaria Capobianchi; F De Marco; Pierangelo Di Marco; M Gentile; Guido Antonelli; P Amicucci; A Cefaro; V Ruggiero; Ombretta Turriziani
[Acid-labile alpha interferon produced by peripheral blood mononuclear cells stimulated by cells infected by HIV].
Annali di igiene : medicina preventiva e di comunità 1989;1(3-4):647-60.
1989: V Ruggiero; Guido Antonelli; G Conciatori; M Gentile; J Van Damme; Ferdinando NMN Dianzani
The in vitro antiviral activity of tumor necrosis factor (TNF) in WISH cells is mediated by IFN-beta induction.
Antiviral research 1989;11(2):77-88.
1989: Roberto Paganelli; Maria Rosaria Capobianchi; Gianpiero D'Offizi; Ivano Mezzaroma; M Cherchi; Pierangelo Di Marco; Ferdinando NMN Dianzani; Fernando Aiuti
Alpha interferon treatment in HIV infected patients restores gamma interferon production in vitro.
Bollettino dell'Istituto sieroterapico milanese 1989;68(1):67-71.
1989: Ferdinando NMN Dianzani; Guido Antonelli
Physiological mechanisms of production and action of interferons in response to viral infections.
Advances in experimental medicine and biology 1989;257():47-60.
1988: Guido Antonelli; P Amicucci; A Cefaro; Clara Maria Ausiello; F Malavasi; Ferdinando NMN Dianzani
Mechanism of human interferon-gamma production: involvement of beta-2-microglobulin.
Cellular immunology 1988;115(1):156-64.
1988: Guido Antonelli; Ferdinando NMN Dianzani; J Van Damme; P Amicucci; F De Marco; A Cefaro
A macrophage-derived factor different from interleukin 1 and able to induce interferon-gamma and lymphoproliferation in resting T lymphocytes.
Cellular immunology 1988;113(2):376-86.
1988: Roberto Paganelli; Maria Rosaria Capobianchi; B Ensoli; Gianpiero D'Offizi; J Facchini; Ferdinando NMN Dianzani; Fernando Aiuti
Evidence that defective gamma interferon production in patients with primary immunodeficiencies is due to intrinsic incompetence of lymphocytes.
Clinical and experimental immunology 1988;72(1):124-9.
1988: Guido Antonelli; V Ruggiero; A Cefaro; Pierangelo Di Marco; P Amicucci; V Colizzi; Ferdinando NMN Dianzani
Early steps in interferon-gamma production: possible involvement of Ca2+-calmodulin-dependent enzymes.
Journal of interferon research 1988;8(2):193-200.
1988: Maria Rosaria Capobianchi; F De Marco; Pierangelo Di Marco; Ferdinando NMN Dianzani
Acid-labile human interferon alpha production by peripheral blood mononuclear cells stimulated by HIV-infected cells.
Archives of virology 1988;99(1-2):9-19.
1988: Ferdinando NMN Dianzani; Guido Antonelli; Maria Rosaria Capobianchi; F De Marco
Replication of human immunodeficiency virus: yield of infectious virus under single growth cycle conditions.
Archives of virology 1988;103(1-2):127-31.
1988: Maria Rosaria Capobianchi; F Malavasi; Pierangelo Di Marco; Ferdinando NMN Dianzani
Differences in the mechanism of induction of interferon-alpha by herpes simplex virus and herpes simplex virus-infected cells.
Archives of virology 1988;103(3-4):219-29.
1987: Franco Mandelli; Arturo Cafolla; Luciana Annino; S Amadori; A Gentile; P Bianco; Ferdinando NMN Dianzani
The alpha 2 (r) interferon in the treatment of hairy cell leukemia: progressive report of 25 cases.
Journal of biological regulators and homeostatic agents 1987;1(4):177-82.
1987: Maria Rosaria Capobianchi; G Lorino; M T Lun; Carlo Mancini; Pierangelo Di Marco; Ferdinando NMN Dianzani
Membrane interactions involved in the induction of interferon-alpha by Mycoplasma pneumoniae.
Antiviral research 1987;8(3):115-24.
1987: Andrea Fattorossi; Antonina Dolei; J G Pizzolo; Arturo Cafolla; Franco Mandelli; Ferdinando NMN Dianzani
Recombinant interferon alpha-2 modulates hairy cell phenotype "in vitro".
Journal of biological regulators and homeostatic agents 1987;1(2):87-92.
1986: Franco Mandelli; Luciana Annino; Arturo Cafolla; Giulio De Rossi; P Bianco; L Fontana; Ferdinando NMN Dianzani
Hairy cell leukemia: preliminary results with alpha 2 (r) interferon.
Tumori 1986;72(2):153-6.
1985: Maria Rosaria Capobianchi; J Facchini; Pierangelo Di Marco; Guido Antonelli; Ferdinando NMN Dianzani
Induction of alpha interferon by membrane interaction between viral surface and peripheral blood mononuclear cells.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1985;178(4):551-6.
1984: Roberto Paganelli; Maria Rosaria Capobianchi; Paolo M Matricardi; L Cioè; R Seminara; Ferdinando NMN Dianzani; Fernando Aiuti
Defective interferon-gamma production in ataxia-telangiectasia.
Clinical immunology and immunopathology 1984;32(3):387-91.
1984: Paolo M Matricardi; Maria Rosaria Capobianchi; Roberto Paganelli; J Facchini; Maria Caterina Sirianni; R Seminara; Ferdinando NMN Dianzani; Fernando Aiuti
Interferon production in primary immunodeficiencies.
Journal of clinical immunology 1984;4(5):388-94.
1984: Ferdinando NMN Dianzani; Maria Rosaria Capobianchi; J Facchini
Role of calcium in gamma interferon induction: inhibition by calcium entry blockers.
Journal of virology 1984;50(3):964-5.
1968: G Gagnoni; P Cantagalli; A Grasso; Ferdinando NMN Dianzani
[Action of some chemical reagents on the active protein groups of the hemagglutinin of rubella virus].
Atti della Accademia dei fisiocritici in Siena. Sezione medico-fisica 1968;17(1):121-7.
1966: G Rita; Ferdinando NMN Dianzani
[Etiology and epidemiology of measles].
Giornale di malattie infettive e parassitarie 1966;18(2):55-81.
1966: Ferdinando NMN Dianzani; G Gagnoni; G Rita
[Some biological properties of 2 variants of the measles virus plaque].
Nuovi annali d'igiene e microbiologia 1966;17(1):49-50.
1964: A GRASSO; U RUBBIANI; Ferdinando NMN Dianzani
[RESEARCH ON THE APPLICABILITY OF A MICROMETHOD FOR SEROLOGIC INVESTIGATION OF VIRAL DISEASES].
Nuovi annali d'igiene e microbiologia 1964;15():358-64.
1964: Ferdinando NMN Dianzani
[Studies on the hemagglutinin of measles virus. Action of various reducing agents].
Bollettino della Società italiana di biologia sperimentale 1964;40(7):302-5.
1964: Ferdinando NMN Dianzani; U RUBBIANI
[DETERMINATION OF MEASLES ANTIBODIES IN PAIRED SAMPLES OF MATERNAL AND FETAL BLOOD].
Nuovi annali d'igiene e microbiologia 1964;15():31-6.
1961: Ferdinando NMN Dianzani
[Recent contributions on the measles virus in reference to the biology of the virus and to the epidemiological and prophylactic aspects of the human infection].
Annali Sclavo; rivista di microbiologia e di immunologia 1961;3():425-76.
1956: Ferdinando NMN Dianzani; L FISCHER-FANTUZZI; G RITA; M RUSSI
[Culture in vitro of human amnion and chorion cells; behavior of Coxsackie virus].
Rivista dell'Istituto sieroterapico italiano 1956;31(3):286-9.